Prot# D9770C00011: A 4-wk, Randomised, Double-Blind, Multicenter, Dose-Finding Phase IIb Study w/AZD0865 25,50,75mg & Esomeprazole 20mg, Given Orally 1x Daily for the Treatment of GERD w/out Erosive Esophagitis According to the LA Classification in Adult

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date10/13/04 → 4/11/07

    Funding

    • National Science Foundation (CMMI-0555485/001)